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Development and application of a universal Hemoplasma 
screening assay based on the SYBR green PCR principle
Abstract
Hemotropic mycoplasmas (hemoplasmas) are the causative agents of infectious anemia in several
mammalian species. Their zoonotic potential has recently been substantiated by the identification of a
feline hemoplasma isolate in an immunocompromised human patient. Although species-specific
diagnostic molecular methods have been developed, their application as screening tools is limited due to
the species diversity of hemoplasmas. The goals of this study were to develop a universal hemoplasma
screening assay with broad specificity based on the SYBR green PCR principle, to compare the assay
with hemoplasma-specific TaqMan PCR, and to analyze potential tick vectors and human blood samples
to address the zoonotic potential. The newly developed PCR assay based on the 16S rRNA gene
amplified feline, canine, bovine, porcine, camelid, and murine hemoplasmas, as well as Mycoplasma
penetrans and Mycoplasma pneumoniae. The lower detection limit for feline and canine hemoplasmas
was 1 to 10 copies/PCR. The assay exhibited 98.2% diagnostic sensitivity and 92.1% diagnostic
specificity for feline hemoplasmas. All 1,950 Ixodes ticks were PCR negative, suggesting that Ixodes
ticks are not relevant vectors for the above-mentioned hemoplasma species in Switzerland. None of the
414 blood samples derived from anemic or immunocompromised human patients revealed a clear
positive result. The SYBR green PCR assay described here is a suitable tool to screen for known and
so-far-undiscovered hemoplasma species. Positive results should be confirmed by specific TaqMan PCR
or sequencing.
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Hemotropic mycoplasmas (hemoplasmas) are the causative agents of infectious anemia in several mamma-
lian species. Their zoonotic potential has recently been substantiated by the identification of a feline hemo-
plasma isolate in an immunocompromised human patient. Although species-specific diagnostic molecular
methods have been developed, their application as screening tools is limited due to the species diversity of
hemoplasmas. The goals of this study were to develop a universal hemoplasma screening assay with broad
specificity based on the SYBR green PCR principle, to compare the assay with hemoplasma-specific TaqMan
PCR, and to analyze potential tick vectors and human blood samples to address the zoonotic potential. The
newly developed PCR assay based on the 16S rRNA gene amplified feline, canine, bovine, porcine, camelid, and
murine hemoplasmas, as well as Mycoplasma penetrans and Mycoplasma pneumoniae. The lower detection limit
for feline and canine hemoplasmas was 1 to 10 copies/PCR. The assay exhibited 98.2% diagnostic sensitivity
and 92.1% diagnostic specificity for feline hemoplasmas. All 1,950 Ixodes ticks were PCR negative, suggesting
that Ixodes ticks are not relevant vectors for the above-mentioned hemoplasma species in Switzerland. None of
the 414 blood samples derived from anemic or immunocompromised human patients revealed a clear positive
result. The SYBR green PCR assay described here is a suitable tool to screen for known and so-far-undiscov-
ered hemoplasma species. Positive results should be confirmed by specific TaqMan PCR or sequencing.
Hemotropic mycoplasmas, also known as hemoplasmas, are
small, pleomorphic, cell wall-free bacteria that have been de-
tected in the blood of various mammalian species (17). Orig-
inally classified as Haemobartonella and Eperythrozoon species
within the order Rickettsiales, these organisms have recently been
reclassified within the genus Mycoplasma (17, 19, 21, 27).
Hemotropic mycoplasmas are clinically relevant as causative
agents of acute, life-threatening hemolytic anemia in infected
animals. Some animals, however, develop only mild clinical signs
or remain asymptomatic. Many cofactors, such as gender, age,
immune status, or coinfection with other pathogenic agents, have
been proposed to be involved in the development of disease
(10, 16, 25, 32). It is thought that animals become chronic,
asymptomatic carriers after infection, although clearance of
the infectious agents from the host blood has been reported
(26, 32, 33).
To date, hemoplasmas have been documented in numerous
mammalian species (Table 1). The close relationship between
the feline hemoplasma “Candidatus Mycoplasma turicensis”
and rodent hemoplasmas and the similarity of feline and ca-
nine hemoplasmas suggest potential interspecies transmission
of these agents (24, 33). This is especially important since
hemotropic mycoplasmas are thought to be transmitted by
blood-sucking arthropods such as ticks, fleas, and lice, given
that these agents have been hypothesized to exhibit zoonotic
potential. Some authors have described organisms with mor-
phological similarities to hemotropic mycoplasmas in the blood
of human patients (3, 7, 14, 22, 37). Furthermore, a recently
published report demonstrating the molecular detection of a
feline hemoplasma species in an immunocompromised human
patient further substantiated the zoonotic potential of these
agents (6).
No in vitro cultivation system has been established to culti-
vate these organisms outside their hosts, and diagnosis of in-
fection relies mainly upon the molecular detection of hemo-
plasmal genes in blood or tissue samples. Specific conventional
and quantitative real-time TaqMan PCR systems have been
established to diagnose hemotropic mycoplasmas (5, 11, 13, 18,
20, 25, 32). These assays provided the initial insight into the
epidemiology and pathogenesis of hemoplasmas; however,
conventional PCR is laborious and prone to carryover of PCR
amplicons. Real-time TaqMan PCR assays, on the other hand,
allow quantification, have minimal risk of amplicon carryover
(being closed-tube systems), and are highly specific due to the
use of a third labeled oligonucleotide. However, because of
their high specificity, these assays are unlikely to detect novel
hemoplasma species.
Real-time SYBR green PCR assays combine the advantages
of conventional and real-time PCR methods. They employ two
primers and a dye (SYBR green) in a closed-tube system. The
SYBR green principle allows for quantification, and its speci-
ficity is less restrictive than that of TaqMan PCR assays. Fur-
thermore, melting curves that differentiate between various
PCR amplicons can be generated after PCR amplification.
The goals of this study were to develop a universal hemo-
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suisse-Faculty, University of Zurich, Winterthurerstrasse 260, 8057
Zurich, Switzerland. Phone: 41 (44) 635 83 22. Fax: 41 (44) 635 89 23.
E-mail: rhofmann@vetclinics.uzh.ch.
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plasma screening assay based on the SYBR green PCR prin-
ciple, to compare the assay to specific TaqMan PCR assays,
and to screen potential tick vectors and blood samples from
anemic or immunocompromised human patients to address zoo-
notic potential and elucidate the possible occurrence of human
hemotropic mycoplasmas by means of molecular methods.
MATERIALS AND METHODS
Samples. For optimization of the SYBR green PCR assay and comparison
with specific TaqMan PCR assays, nucleic acid (NA) samples from 99 felids (42
uninfected, 15 singly infected, and 42 coinfected with feline hemoplasmas) were
included. The samples were obtained from 35 specific-pathogen-free cats (4), 19
Swiss pet cats (32), and 45 African lions (Panthera leo) (35). The pet cats and
lions had been analyzed for the presence of feline hemoplasmas by specific
real-time TaqMan PCR assays (32, 35). The lions were included in the study
because they are commonly coinfected with feline hemoplasmas (35).
To address the zoonotic potential of hemoplasmas, NA samples from a total
of 1,950 Ixodes ticks collected from the vegetation in the area around Zurich,
Switzerland, by the cloth-dragging method were included (34). The arthropods
were mechanically disrupted with sterile scalpel blades and homogenized in a
Mixer Mill MM 300 device (Retsch GmbH, Haan, Germany), and NA was
extracted with a MagNA Pure LC TNA isolation kit (Roche Diagnostics, Rot-
kreuz, Switzerland) as described previously (34). After NA extraction, the sam-
ples were subjected to an 18S rRNA gene real-time PCR assay as described
previously (34) to confirm the presence of amplifiable NA and exclude PCR
inhibition.
Furthermore, EDTA-anticoagulated blood samples from 414 anonymous hu-
man patients were used, including 200 blood samples collected from immuno-
compromised patients from Zimbabwe infected with human immunodeficiency
virus (HIV) and 214 blood samples from immunocompromised or anemic pa-
tients from Switzerland. NA was purified from 100 l of human blood using the
MagNaPure LC TNA isolation external lysis protocol (Roche Diagnostics) with
a final elution volume of 100 l. To monitor cross-contamination, negative
controls consisting of 100 l of phosphate-buffered saline were prepared con-
currently with each batch of 15 samples.
SYBR green real-time PCR primer design. To design primers for a universal
hemoplasma SYBR green PCR assay, the 16S rRNA genes of the following hemo-
tropic Mycoplasma species were retrieved from GenBank and aligned using the
GCG Wisconsin Package (Accelrys GmbH, Munich, Germany) and ClustalW (29):
M. haemofelis (accession no. DQ157160), “Candidatus Mycoplasma haemominu-
tum” (DQ157149), “Candidatus Mycoplasma turicensis” (DQ464421), M. haemoca-
nis (EF416568), “Candidatus Mycoplasma haematoparvum” (EF416569), M. suis
(AY492086), M. wenyonii (DQ641256), “Candidatus Mycoplasma haemobovis”
(EF616468), M. ovis (AF338268), M. haemomuris (U82963), M. coccoides
(AY171918), M. erythrodidelphis (AF178676), “Candidatus Mycoplasma haemo-
lamae” (AF306346), and “Candidatus Mycoplasma kahanei” (AF338269). One for-
ward and two reverse primers were designed using Primer Express software v2.0
(Applied Biosystems, Rotkreuz, Switzerland) (Table 1). The two reverse primers
were used as a 1:1 mixture in the SYBR green PCR.
SYBR green real-time PCR primer optimization. For SYBR green PCR op-
timization, a primer matrix containing forward or reverse primer concentration
combinations of 50 nM, 300 nM, and 900 nM was assessed using plasmids
containing the nearly full-length 16S rRNA genes of M. haemofelis, “Candidatus
Mycoplasma haemominutum,” and “Candidatus Mycoplasma turicensis” as tar-
get templates (32, 33) or no-template controls (NTC). The three target templates
(positive controls) were chosen because each represents a member of the three
distinct phylogenetic clusters of hemoplasmas (17). The reaction mixture was
composed of 12.5 l of 2 SYBR green PCR master mix (Applied Biosystems),
50 to 900 nM concentrations of the forward and reverse primers, and 5 l of NA
template brought to a total volume of 25 l with water. Assays were performed
using an ABI Prism 7700 sequence detection system (Applied Biosystems). The
SYBR green PCR protocol comprised 50°C for 2 min and 95°C for 10 min,
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. After the PCR run,
dissociation was performed with the following thermal profile: 95°C for 15 s, 60°C
for 20 s, an increase from 60°C to 95°C for 20 min, and finally 95°C for 15 s. The
minimum primer concentration demonstrating the maximum difference in fluo-
rescence intensity (Rn) was determined. Rn was calculated by the ABI Prism
7700 sequence detection system as described previously (2).
SYBR green real-time PCR master mix optimization. Using the optimized
primer concentration and the PCR cycle conditions mentioned above, the SYBR
green PCR master mix (Applied Biosystems) was compared to two additional
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SYBR green PCR master mixes: Power SYBR green PCR master mix (Applied
Biosystems) and QuantiTect SYBR green master mix (Qiagen, Hombrechtikon,
Switzerland). For this purpose, cats singly infected (n  8) or coinfected (n  3)
with the three feline hemoplasmas and hemoplasma-uninfected cats (n  11),
based on the results of specific TaqMan PCR, were selected from the above-
mentioned samples and run with the three different master mixes. In each PCR
run, positive controls and NTC were included. The diagnostic accuracy was
calculated (diagnostic accuracy [%]  number of correctly classified samples/
number of tested samples) (23), and the master mix demonstrating maximal
diagnostic accuracy was selected for further analyses.
SYBR green real-time PCR specificity and sensitivity. Using the optimized
primer concentration and master mix, NA samples from the following bacteria
were used to determine the specificity of the SYBR green PCR assay: M.
haemofelis, “Candidatus Mycoplasma haemominutum,” “Candidatus Myco-
plasma turicensis,” M. haemocanis, “Candidatus Mycoplasma haematoparvum,”
M. suis, M. wenyonii, “Candidatus Mycoplasma haemobovis,” “Candidatus My-
coplasma haemolamae,” M. coccoides, M. pneumoniae, M. penetrans, M. equigeni-
talium, M. argini, M. agalactiae, Chlamydophila felis, Pasteurella multocida, and
Cytauxoon felis.
To determine the sensitivity of the assay for canine and feline hemoplasmas,
recently published linearized plasmid standards containing the cloned 16S rRNA
genes of M. haemofelis, “Candidatus Mycoplasma haemominutum,” “Candidatus
Mycoplasma turicensis,” and “Candidatus Mycoplasma haematoparvum” were
used (30, 32, 33). The amplification efficiency was calculated as R  101/slope 
1 (15).
Comparison of the SYBR green PCR assay with specific real-time TaqMan
assays. For comparison with the universal SYBR green PCR assay, specific
real-time TaqMan PCR assays for the detection of M. haemofelis, “Candidatus
Mycoplasma haemominutum,” and “Candidatus Mycoplasma turicensis” were
performed as previously described (32, 33). Of the above-mentioned NA sam-
ples, 93 were used for comparison. They comprised samples from 38 uninfected
cats, 15 singly infected cats, and 40 cats coinfected with feline hemoplasmas, as
assessed by the specific TaqMan PCR assays.
Statistical evaluation. For primer concentration optimization, the Rns of the
two primer groups (group 1, primer combinations containing 50 nM; group 2,
primer combinations containing 300 nM or 900 nM) were compared using the
nonparametric Mann-Whitney U test. Differences with a P value of 0.05 were
considered significant.
RESULTS
SYBR green PCR assay primer design. Forward and reverse
primers were designed based on published hemotropic Myco-
plasma 16S rRNA gene sequences (Table 1). Sequence align-
ment revealed up to two mismatches in the forward or reverse
primer sequence when aligned with those of known hemo-
plasma species (Table 1). No mismatches were located near
the 3 ends of the primer sequences.
SYBR green PCR assay optimization. For all three feline
hemoplasmas, all primer combinations containing concentra-
tions of 50 nM resulted in significantly lower Rn values than
for the remaining primer combinations containing only 300
and/or 900 nM (M. haemofelis, P  0.016; “Candidatus Myco-
plasma haemominutum,” P  0.016; and “Candidatus Myco-
plasma turicensis,” P  0.016). Among the four giving high
Rn values, the minimum primer concentration was selected;
thus, final primer concentrations of 300 and 300 nM were used
for further testing. Three master mixes were then evaluated,
and the diagnostic accuracy was assessed (Table 2). Based on
the highest diagnostic accuracy of the SYBR green PCR mas-
ter mix (86%), it was used for further testing.
SYBR green PCR specificity and sensitivity. All 10 hemo-
tropic mycoplasmas tested were amplified using the SYBR
green PCR assay. M. pneumoniae and M. penetrans, two my-
coplasmas that are closely related to the hemotropic Myco-
plasma group, were also amplified, whereas the remaining
agents listed in Materials and Methods revealed threshold
cycle (CT) values in the range of those for the NTC.
The lower detection limit for the tested feline and canine
standards ranged from 1 to 10 copies/PCR. Amplification ef-
ficiencies were calculated using the same threshold and base-
line for all four standard curves (threshold, 0.283; baseline, 3 to
10). Amplification efficiencies were 92.0%.
Melting curve analysis of SYBR green PCR products. In
animals infected with a single hemoplasma species, the melting
temperature (Tm) was distinctly different among the three fe-
line, two canine, and two bovine hemoplasmas (Table 3 and
Fig. 1). In hemoplasma-coinfected animals, species differenti-
ation was not possible due to Tm variability among the ampli-
fication products.
Nonspecific product formation. When nonspecific product
formation was found, it was commonly observed in the NTC
rather than in the uninfected samples. The CT values ranged
from 34.4 to 39.9, corresponding to 10 copies/PCR. Because
the Tm reported for primer dimers (about 75°C) (2) is in the
range of the Tms for the different hemoplasmas (Table 3),
differentiation of primer dimers and specific product formation
by melting curve analysis was not possible.
Comparison of the universal SYBR green PCR assay with
specific TaqMan PCR assays. NA samples extracted from 93
felines were used for comparison. Using SYBR green PCR, 54
out of 55 infected and 35 out of 38 uninfected samples were
correctly identified (Table 4). The SYBR green assay exhibited
98.2% diagnostic sensitivity and 92.1% diagnostic specificity
compared to feline hemoplasma-specific TaqMan PCR assays.
TABLE 2. Diagnostic accuracy of the three tested SYBR green
PCR master mixes compared to feline hemoplasma-specific
TaqMan PCR
Master mix SYBR greenPCR result
No. of samples with
TaqMan PCR:
Diagnostic
accuracy
(%)Positive Negative
SYBR green PCR
master mix
Positive 9 1 86
Negative 2 10
Power SYBR green
PCR master mix
Positive 10 4 77
Negative 1 7
QuantiTect SYBR
green master mix
Positive 11 7 68
Negative 0 4
TABLE 3. Tms of the tested hemotropic Mycoplasma species as
assessed by melting curve analyses
Species Tm (°C)a
M. hemofelis .................................................................................74.5–76.0
“Candidatus Mycoplasma hemominutum”...............................73.0–74.5
“Candidatus Mycoplasma turicensis”........................................76.0–77.5
M. hemocanis ............................................................................... 75.0
“Candidatus Mycoplasma hematoparvum” ..............................73.0–74.0
M. suis ........................................................................................... 76.5
M. wenyonii................................................................................... 76.5
“Candidatus Mycoplasma hemobovis”...................................... 74.0
M. coccoides ................................................................................. 74.5
“Candidatus Mycoplasma hemolamae” ....................................73.5–74.0
a When multiple samples were analyzed, the melting temperature range is
specified.
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The one “Candidatus Mycoplasma haemominutum”-infected
sample that was not detected by the SYBR green assay was
obtained from a Swiss pet cat. By quantitative real-time Taq-
Man PCR, this animal had a hemoplasma blood load of 1,960
copies/ml of blood. The three hemoplasma-uninfected samples
that displayed a positive result in SYBR green PCR but a
negative result in specific TaqMan PCR assays were obtained
from two specific-pathogen-free cats and one African lion.
Ticks. In order to assess whether hemoplasmas could be
found in the most common tick in Switzerland, Ixodes ricinus,
and pose a potential zoonotic risk, 1,950 unfed Ixodes ticks
were analyzed. All NA samples extracted from ticks tested 18S
rRNA PCR positive (CT values of 27), confirming the pres-
ence of amplifiable NA and the absence of relevant PCR
inhibition. In SYBR green PCR, all 1,950 samples revealed
PCR-negative results for hemoplasma species.
Human blood samples. None of the 414 human blood sam-
ples revealed clear positive results. Five blood samples from
immunocompromised patients from Switzerland exhibited CT
values that were slightly below 40 (range from 39.2 to 39.9,
corresponding to 1 copy/PCR); however, CT values in this
range were also observed for some NTC. The high CT values
did not allow for further analysis, e.g., by sequencing.
DISCUSSION
The universal SYBR green PCR assay described here was
designed as a quantitative, closed-tube method for inexpensive
and rapid screening of samples for hemotropic Mycoplasma
species. The assay was shown to amplify all 10 hemoplasma
species tested, including feline, canine, bovine, porcine, cam-
elid, and murine hemoplasmas. To the best of our knowledge,
no other hemoplasma PCR assay published thus far has been
able to amplify that many different hemoplasma species. For
feline hemoplasmas, the assay exhibited 98% diagnostic sensi-
tivity. Because high assay sensitivity is a prerequisite for the
detection of infections at low prevalence, our assay represents
an excellent hemoplasma screening method. Recently, the
number of reported hemoplasma species in mammals has
steadily increased, and the universal SYBR green PCR assay,
with its broad specificity, represents an important tool to sim-
plify and boost the search for other, thus-far-unknown hemo-
plasma species.
The recent identification of the feline hemoplasma M. hae-
mofelis in an immunocompromised HIV-positive patient in
Brazil represents the first report of human hemoplasma infec-
tion based on molecular methods (6). This discovery supports
the hypothesis of the zoonotic potential of these agents and
underscores the importance of searching for hemoplasma spe-
cies in humans using assays with broad specificity. Through
testing of human blood samples from Switzerland and Zimba-
bwe, patients living in different climate zones and social envi-
ronments were included in the present study. All human pa-
tients were either anemic or immunocompromised and therefore
were assumed to be at risk of hemoplasma infection. Further-
more, a remarkably high hemoplasma prevalence was recently
reported in cats in South Africa and dogs in Sudan (12, 28, 36),
and hemoplasmas were detected in lions and in ticks collected
from lions in Tanzania (8, 35). Nonetheless, none of the human
blood samples tested here were PCR positive.
Melting curve analysis is commonly used to differentiate
amplicons after SYBR green PCR. The Tm depends on both
the PCR amplicon size and the GC content. In the present
FIG. 1. Melting curve analysis after hemoplasma SYBR green PCR of samples from animals infected singly with a feline, canine, murine, or
porcine hemoplasma species. Each curve represents one PCR amplicon and depicts the change in fluorescence during a continuous increase in
temperature. The temperature demonstrating the peak change in fluorescence represents the Tm.
TABLE 4. Comparison of the results obtained by universal
hemoplasma SYBR green PCR and feline
hemoplasma-specific TaqMan PCR
TaqMan PCR-positive
hemoplasma species
Total no. of
samplesa
No. SYBR
green PCRb:
Positive Negative
M. hemofelis 5 5 0
“Candidatus Mycoplasma
hemominutum”
8 7 1
“Candidatus Mycoplasma turicensis” 2 2 0
M. hemofelis-“Candidatus
Mycoplasma hemominutum”
5 5 0
“Candidatus Mycoplasma
hemominutum”-“Candidatus
Mycoplasma turicensis”
10 10 0
M. hemofelis-“Candidatus
Mycoplasma hemominutum”-
“Candidatus Mycoplasma
turicensis”
25 25 0
Total
Positive 55 54 1
Negative 38 3 35
Total no. 93 57 36
a Number of samples uninfected, singly infected, or coinfected with feline
hemoplasmas, as assessed by specific TaqMan PCR assays.
b Results based on melting curve analysis.
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study, melting curve analysis revealed different Tm values for
the three feline, two canine, and two bovine hemoplasmas. The
Tm value was unpredictable, however, in samples containing
two or more hemoplasma species, suggesting that species dif-
ferentiation in coinfected animals is not feasible. Similar re-
sults have recently been reported for other SYBR green PCR
assays (9). Since coinfection with different hemoplasma species
is very common (20, 32, 35, 36), species-specific TaqMan PCR
assays or sequencing of PCR products remains a prerequisite
for specification of the hemoplasma species present in coin-
fected animals.
In some instances, low-level nonspecific product formation
was observed. According to the manufacturer’s instructions (2),
the weakly positive signals probably represent primer dimer
formation or elongation of primers nonspecifically bound to
genomic DNA. Because the Tms for the tested hemoplasma
species ranged from 73.0°C to 77.5°C, discrimination of primer
dimer formation (with a reported Tm of 75°C) and specific
product formation by melting curve analysis was not feasible.
All 1,950 Ixodes ticks investigated in the present study tested
negative by SYBR green PCR, suggesting that these ticks do
not play a role in the transmission of the hemoplasma species
detected by our assay in Switzerland. This extends our recent
results showing that Ixodes ticks are not a relevant vector for
feline hemoplasmas in Switzerland (34). Since Ixodes ricinus
represents the most common tick species in Switzerland (1,
31), vector-borne transmission of hemoplasmas via ticks from
animals to humans in Switzerland seems unlikely.
In conclusion, the present study demonstrates that the
SYBR green PCR assay described here is suitable to screen for
known and so-far-undiscovered hemoplasma species. Positive
results should be confirmed by species-specific TaqMan PCR
assays or sequencing of the PCR products. Despite the recent
molecular detection of M. haemofelis infection in an HIV-
positive patient, in this study no hemoplasma infections were
detected in blood samples derived from anemic or immuno-
compromised humans. The question of whether undiscovered
hemoplasma species could play a role in human health should
be addressed in subsequent studies. The assay described here
will be an important tool in the pursuit of this issue.
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